华熙生物：股东国寿成达持股比例降至5.89%

Core Points - Huaxi Bio announced that shareholder Guoshou Chengda reduced its stake by 571,800 shares through centralized bidding on November 26, 2025, decreasing its holding from 6.01% to 5.89% [1] - The equity change does not violate any commitments, intentions, or plans previously made, and it does not trigger mandatory tender offer obligations [1]